Press Releases

January 21, 2014 • 12:49 PM EST

Clinton Portis, Jeremy Shockey, Dr. Robert Stern and NFL Network's Andrea Kremer Join #C4CT Concussion Awareness Summit at the United Nations During Super Bowl Week

January 15, 2014 • 10:00 AM EST

Amarantus Founders Gerald and Dr. John Commissiong Selected as Black Money's "50 Most Important African-Americans in Technology"

January 14, 2014 • 6:00 AM EST

Amarantus In-Licenses Levadopa-Induced Dyskinesia Phase 2b-Ready Eltoprazine From PGI Drug Discovery

January 9, 2014 • 3:50 PM EST

Gerald Commissiong, CEO of Amarantus to Participate in Twitter Chat, "The Human Brain"

January 6, 2014 • 7:30 AM EST

Amarantus to Present at Biotech and Healthcare Conferences During JP Morgan Week in San Francisco

December 18, 2013 • 6:00 AM EST

Amarantus Licenses MANF-Related Wolfram's and Diabetes Therapeutic and Diagnostic Intellectual Property From University of Massachusetts Medical School

December 17, 2013 • 9:54 AM EST

Amarantus and Brewer Sports Announce ONE MIND for Research at 2nd #C4CT Concussion Awareness Summit Prior to Super Bowl XLVIII at United Nations

December 3, 2013 • 8:00 AM EST

Amarantus Obtains Exclusive Option to License University of Miami Bascom Palmer Eye Institute's Intellectual Property for the Treatment of Retinal Diseases Using MANF and CDNF

November 26, 2013 • 9:19 AM EST

Amarantus BioScience to Present at the LD Micro Sixth Annual Conference on December 3, 2013

November 14, 2013 • 4:15 PM EST

Amarantus Reports Third Quarter 2013 Financial Results and Development Progress